The mechanism which 'adapts' the T-cell antigen receptor (TCR) repertoire within a given major histocompatibility complex (MHC; HLA, in humans) genotype is essential for protection against rapidly dividing pathogens. Historically attributed to relative affinity, genetically vast TCRs are surprisingly "focused" towards a micromolar affinity for their respective pHLA ligands. Thus, the somatic diversity of the TCR with respect to MHC restriction, and (ultimately) to pathogens, remains enigmatic. Here, we derive a triple integral equation (from fixed geometry) for any given V-domain in TCR bound to pMHC. We examined solved complexes involving HLA-DR and HLA-DQ, where all the available structures are still reasonably analysed. Certain V-beta domains displayed "rare" geometry within this panelspecifying a very low ("highly-restricted") rotational probability/volumetric density (dV). Remarkably, hydrogen (H)-bond charge-relays spanning CDR3-beta, the peptide, and polymorphic MHC distinguished these structures from the others; suggesting that CDR3 binding chemistry dictates CDR2 'scanning' on the respective MHC-II alpha-helix. Taken together, this analysis (n = 38 V-domains) supports a novel geometric theory for MHC restriction-one not constrained by a thymus "optimized" TCR-affinity.
Introduction:
For better and (for) worse all the biology of the adaptive immune system cascades from a stochastic genetic mechanism (somatic DNA rearrangement)-generating TCR and antibodies (sIg) "individualized" within each precursor of a given T-cell or B-cell clone [1] [2] [3] [4] . TCR (here-in, refers to /-type only) are utilized against antigenic structures which are all partially similarall are MHC (human, HLA) proteins transporting a single 8-25 amino acid (a.a.) peptide (abbrv., pMHC). The peptide component is extremely variable however; derived from intra-cellular, proteolytic 'processing' of virtually any self, or non-self protein [4, 5] . In-fact, TCR diversity exceeds Ig diversity, although antibodies historically defined a 'V-region,' e.g., their elicitation against hitherto not-synthesised organic structures [6] . Classic MHC class-I (HLA-A, -B, -C) and -II (HLA-DR, -DQ, -DP) genes include the most polymorphic in the human genome, yet the germline limits diversity to the alleles on maternal and paternal sixth chromosomes [5, 7, 8] . Thus, despite extreme MHC polymorphism within the population, and co-dominance within the individual, overwhelmingly, most of the diversity in a patient's pMHC structures stem from the peptide possibilities for these ligands-indeed, the 'hyper-variant' CDR3 loops are positioned (conspicuously) atop the peptide component in solved TCR:pMHC complexes [9] [10] [11] [12] [13] [14] [15] ; although recent investigations have challenged ubiquity of this structure/function [16] [17] [18] .
For example, we previously reported that one of the CDR3 loops (CDR3) also makes consistently close contacts with a conserved HLA-A component, i.e., the R65-motif (a.a., R65-X-X-K68-A69-X-S71-Q72) [17] . Burrows et al. , also found conserved CDR3 contacts directly with MHC-I [19] . More recently, Sharon et al formally linked germline TCR usage to HLA, particularly via the class-II alleles [15] . Here, the STCR-Dab (http://opig.stats.ox.ac.uk/webapps/stcrdab/) was used to identify all current TCR complexes involving HLA-DR and HLA-DQ (as of 07/06/19; 3.0 Å resolution cut-off). Note, also included are PDB 4H1L, at 3.3 Å, and 3T0E, at 4.0 Å (see below), and the 'unusual topology' complexes (PDB 1YMM, 4Y1A & 4Y19) are excluded based on this investigation targeting "characteristic" features.
Using Euler's geometry, we established a simple relationship between the observed (i.e., measured) CDR3-CDR2 "pitch" angle for a given V-domain and its predicted (i.e., calculated) CDR3-CDR2 pitch angle [17] . Here, we found a linear relationship between calculated pitch and a new measure, "dV"-by multivariable calculus. As is discussed, dV interprets V-domain orientation into a rotational probability involving an apparent CDR2-MHC -helix scanning function (d). While dV were unique for each TCR on each pHLA-DR, one TCR displayed a dramatic "restriction" in dV for V. This was isolated to a 'charge-relay' H-bonding mechanism for CDR3; further suggesting the chemistry of "somatic-TCR" might dictate positioning of "germline-TCR" [20] [21] [22] . Within the seven pHLA-DQ structures, the two highly-restricted dV TCR (4OZG & 4OZH) displayed distinct, yet functionally similar mechanisms that shifted the same TCR:MHC H-bond by one MHC a.a. position (relative to the nominal dV structure, 4OZF). Crucially, this involves an additional H-bond (MHC:MHC) in suitable 'charge-relay' mechanisms of 4OZG and 4OZH. We will discuss how these data suggest that TCR binding specificity could be controlled by orientation (dynamics) and not densities of pMHC, or relative forward and reverse rates of the reaction, per se.
Results:
PDB files of solved TCR:pHLA-DR, and TCR:pHLA-DQ structures were used to investigate Vdomain geometry amongst the available complexes, i.e., involving similar (but different) TCR, and/or similar (but different) pMHC. All of these structures share the canonical (diagonal) orientation of the TCR over pMHC, which was one of the earliest observed similarities between different complexes [10] . As indicated in the summary tables (Tables 1A-1D ) some of the structures share the same TCR, where different peptide (2IAM vs. 2IAN), or different DRB1 (1J8H vs. 1FYT; 6CQL vs. 6CQQ vs. 6CQR) were compared. Some structures share pMHC binding different TCR (2IAM vs. 4E41; 6CQL vs. 6CQN; 4OZF-I). All the DR structures share the DRA chain [8, 23] and in some cases, so, too, the DRB1 allotype (2IAM, 2IAN, 4E41, 1FYT, 6CQR; all DRB1-1), (1J8H, 3T0E; both DRB1-4), (6CQL, 6CQN; both DRB1-11); 6CQQ is DRB1-15, 4H1L is DRB3 and 1ZGL is DRB5 (isotypes). The DQ structures are DQ8 (5KSA, 4GG6), DQ2.5 (5SK9), or DQ2.2 (4OZF-I) (NCBI annotation and BLAST; www.ncbi.nlm.nih.gov). While bound peptides in the DR group are of diverse protein origins, all the DQ peptides are wheat gliadins; either the glia-gamma-1, glia-alpha-2, or glia-MM1. Interest in these particular DQ structures is due to celiac disease, an autoimmune-like condition known to be mediated by predominant T-cell clonotypes against ingested wheat. Some 95% of celiac patients express HLA-DQ2.5 (DQA*05/DQB1*02), while the rest are either HLA-DQ8 (DQA*03/DQB1*03:02), or DQ2.2 (DQA*02:01/DQB1*02) [24] . For our purposes, the crystal structures of these nearly identical complexes facilitated isolating the chemistry associated with V-domain rotational probability/volumetric density (dV). Note that all sequences for each component of all of these structures are available under the appropriate PDB file name at the NCBI (www.ncbi.nlm.nih.gov).
TCR-pMHC Geometry
Shown in Figures 1A and 1B is an example of the geometry analysis based on fixed a.a. positions in the HLA-DR, -DQ 'grooves' (e.g., PDB 1J8H).
We originally used Euler angles (www.mathword.wolfram.com/EulerAngles.html) to establish the basic method (for a TCR-V cohort in pHLA-A2 complexes) [17] ; here, we modified the method for the available solved TCR:pHLA-DR, -DQ structures (summarized in Tables 1A-1D ). In brief, the analysis is based on measuring three angles corresponding to the twist (), tilt (), and sway () of each V-domain over the pMHC. (Tables 1A-1D ). All angle measurements were from C in VMD-1.9.1 (www.ks.uiuc.edu) used to examine the diversity through the 38 V-domains: (i) in-plane to the MHC-groove {twist = }, with (ii) displacements perpendicular to the groove {tilt = }, including (iii) side-to-side variation {sway = }. The a.a. positions used as coordinates for angular measures (dotted orange vectors) across structures were fixed and are labelled (see text). The measured "incline" of a V-domain, or "pitch" {pitch =  m }, is shown by white dotted vectors and could be approximated by the equation: Tables 1A-1D ). Side chains of a.a. in measurements are shown by CPK licorice; C-backbones are in new cartoon and labelled; peptides are in black. Note from A to B the view of the structure rotates 180°.
For HLA-DR a vector from the DRA a.a. N62 alpha-carbon (N62:C) to DRB1/3/5 a.a. D66 (D66:C; C used for measurements unless otherwise noted) bisects the MHC-groove from the DRA -helix to the DRB1/3/5 -helix, then the angle at D66 to the V central cysteine (C22) is computed with the VMD angle-label tool. This -angle can be seen in Figure 1A (V) and 1B (V; where the vectors run D66:N62:C23) as dotted orange lines near the melon-coloured "" symbol, 86.88° (V), 84.91° (V). The E11 (beta-sheet floor) to N62 to C22 (tilt-angle) is similarly shown (1A) near the "" symbol, 134.93°; for V, D66 is used (1B), F40:D66:C23, at 109.62°. Finally the -angle is measured from N62:E11:C22 (V) or D66:F40:C23 (V), here at 35.67° and 47.99°, respectively. Analogously for HLA-DQ, TCR:pMHC structures, V twist is based on a DQA a.a. N62:C to DQB D66:C vector bisecting the groove, where the angle vertex is at D66 to V C23:C (not shown). Here, N11:C (not E11 found in DR) to the N62 vertex to C23 defines tilt, and the reverse N62:N11:C23 is sway. For the DQ V's, angles are the same as in DR structures. Specifically, twist is defined by D66:N62:C23, tilt by F40:D66:C23, and sway as D66:F40:C23 (Table 1D ). We formulated the equation:
that predicts the pitch of a given V-domain (pitch = angle ) from the , , and . By contrast, measuring the -angle is based on finding the closest contact between the domain CDR2 and the -helix that is opposite N62 (for V) or D66 (for V) (yellow highlighted in Tables 1A-1D ). The vectors are directed from that CDR2 a.a. to the across-the-groove -helix a.a., then back to the -helix a.a. that is in contact with the CDR2 a.a. (white dotted lines, Figs. 1A & 1B). In Tables 1A-1D the calculated ( c ) and measured ( m ) pitch angles are shown along with the "k" values. Thus, to the extent k approaches 1.00 indicates correlation between the observed pitch and calculated pitch values. Statistics: HLA-DR group: mean k = 0.99 ± 0.36 (s), n = 24, t = 0.915,  0 = 1.00, p = 0.376, 95% CI, 0.880-1.10; (paired Student's t-test; www.graphpad.com/quickcalcs; www.select-statistics.co.uk). HLA-DQ group: mean k = 0.88 ± 0.35 (s), n = 14, t = 1.24,  0 = 1.00, p = 0.234, 95% CI, 0.750-1.01. Overall (DR & DQ): mean k = 0.95 ± 0.35 (s), n = 38, t = 0.85,  0 = 1.00, p = 0.402, 95% CI, 0.870-1.03.
Triple Integrals
We observed that the closest CDR2 contacts with the 2-helix 'across-the-groove' from the conserved R65 contact with CDR3 in HLA-A2 structures specified a polymorphic region from a.a. H/R151 to a.a. A158 [17] . Similarly, the CDR2 closest contacts range for the DR structures here (Tables 1A-1C ) implicate an 2-helix range from a.a. E69 to a.a. T77; CDR2 1-helix contacts range: a.a. Q57 to a.a. K67. For the DQ complexes: CDR2 contacts range is 2-helix a.a. E69 to a.a. D76; CDR2: Q57 to H68 (Table 1D ). Thus, we hypothesized that if these helical a.a. are indeed swept/scanned by CDR2 of the V-domain, that we should be able to model such with integration from spherical coordinates in each structure [25] [26] [27] [28] . To normalize the equation across structures and use the geometry, the central cysteine (C22/23) was chosen as a point rotating from the fixed across-the-groove a.a. position that defines twist, tilt, and sway (Figs. 1 & 2). As shown in Figure 2B , the coordinates model a 'slice' of a cone [26] , where for each of the 38 V-domains we measured the distance between the C22/23 and said -helix a.a. (e.g., 2IAM V measures 22.12 Å)-this is the rho () distance in the equation. The other measure was the angle , which is simply the difference from 180° of the previously determined tilt (angle ). The other variables were derived by trigonometry (see Fig. 2B ). Tables  1A-1D ). For strictly compositional reasons throughout "the triple integral of dV" may be referred to as simply "dV." As discussed above it is not surprising that the (π · r / 4) values were close to the actual distances between CDR2 contacts in the aforementioned MHC -helix ranges using this approach, e.g., 13.27 Å, Figure 2B . Thus, the volume of the cone slice for each Vdomain was determined upon integration for the three spherical coordinates, rho (), theta () and phi (), where the upper limit of each integral is derived from the measured  and  values of each V-domain as shown:
This is integration of a 'volume element' in spherical coordinates (all dV values in
Since  and  are measured for each V-domain, derivation of upper limits for the first and third integrals simply provide trigonometric relationships.
Two example solutions are given below (parameters as defined, Figs. 1 & 2; text)-for all 38 triple integral solutions, see Suppl.1*. The (π · r / 4) circumference segment is used as the upper limit of the d integral because it is accurate to a path, i.e., a distance; formally (for angle in degrees): π · r () / 180 = arc length in Å [26] . Hence, d is the only integrand for conversion (multiplying by π ÷ 180) to yield the cubic angstrom (Å 3 ) unit of volume. The C22/23 cysteine is historically used as the 'center' of any given V-domain [6] and each V-domain 'slice' is thus the volumetric-density through its CDR2 scanning (e.g., Fig. 2B ). The calculus interprets a comprehensive geometry of the V-domain into a probability of scanning using only the ground-state structure, i.e., without crystallographic data on theoretical conformerssuggesting here, a classic protein function, allostery [28, 29] ; see also 'protein machinery' in Discussion.
Accordingly, the mean dV of these TCR V-domains was 955 ± 507 Å 3 , excluding the unusually large dV of the 1ZGL V (see below). Importantly, with the exclusion of 1ZGL (an apparent outlier) there is a linear relationship between calculated pitch ( c ) and the dV triple integral (see plotted values from Tables 1A-1D in the Suppl.2)-corresponding to the equation: y = 83.60x -719. 40 ; where R 2 = 0.900, by linear regression analysis. The lowest dV structures have the lowest calculated pitch values. Overall, it says something about TCR:pMHC that may not be intuitive-that a "flush" V-domain geometry could limit its capacity to "find" a compatible binding interface with side-chains involving the aforementioned -helix regions.
CDR3:pMHC Contacts
Particularly close TCR contacts with an autologous MHC during thymic development could theoretically enhance 'positive selection' [30] . However, some of the CDR2/-helix interface measurements (Tables 1A-1D ) could suggest such TCR are not selected. Alternatively, we know close CDR2 contacts with monomorphic DRA must contribute to linkages between DRB1 and autoimmunity [15] , but considerations here cannot directly exclude 'negative selection' that deletes 'forbidden clones' specific for self-peptide:self-MHC complexes [4] . All these structures, even those with the highest resolution, are subject to limitations of crystallography [15] ; and indeed, we compute the H-bonds based on these coordinates. Nevertheless, we sought a correlation between relative dV and contact distances for hydrogen bonds of the five components; see Tables 2A-2C We examined the structures in Swiss-PDB Viewer/Deepview-v4.1 (www.wpdbv.vital-it.ch); in "Swiss" H-bonds can be computed after hydrogens are added based on coordinates; complexity of certain structures (2IAN, 1ZGL) precluded computing hydrogens, and the shown H-bonding distances are thus ≈ 1 Å larger (Tables 2A, 2B ). Here, an obvious feature of all the complexes is that there are two principal "foci" of H-bonding; one involving N62 of DRA (A1) (shaded orange in the tables), which may include a separate secondary grouping at N69 (light-orange shade), and the DRB1 (B1) centre involving R71 (green shades). Note, R71 is polymorphic, so structures involving allotypes/isotypes that have a different a.a. at pos. 71 (1J8H, 3T0E, 1ZGL, 6CQQ & 4H1L) involve a different a.a. (1J8H, 3T0E, 6CQQ), or simply do not have a corresponding betachain H-bonding centre (4H1L & 1ZGL). Superimposed upon the H-bonding centres are the H-bonds between the CDR3 and peptide, the CDR3 and peptide, any peptide to peptide Hbonding, any intra-or inter-bonds between the TCR V-domains, any MHC to MHC H-bonding, and direct H-bonds between TCR V-domains and the MHC (Tables 2A-2C, columns) .
In all cases, the CDR3:peptide bonds are either non-existent, or isolated from the MHC:peptide centres. In 4E41, 6CQQ and 6CQR, CDR3 may link to CDR3 through both bonding nearby with peptide (blue shading). For 2IAM, 1J8H, and 1FYT there are bonds between intra-V (2IAM), or intra-and inter-V (1J8H, 1FYT), but these are not linked to the peptide (different blue shade). N62 is connected to a peptide:peptide H-bond (4H1L), or to an inter-V bond (3T0E); in both cases these potential networks extend to the V directly binding with N62. 1ZGL is the only structure with an inter-V bond potentially linked to a direct Vdomain interaction with MHC, while 4H1L is unique in not showing any DRB H-bonding involving the CDR3 (recall these two structures involve non-DRB1 isotypes). In 6CQL and 6CQN there is a potential DRB1:peptide link with an MHC:MHC bond, but this does not involve the TCR. The 6CQ series all have CDR3:peptide bonds also involving a peptide:peptide bond; this is not found in any of the other complexes (mauve shading). Finally, and most significantly here, in 2IAM, 2IAN, 1FYT and 3T0E the DRB1:peptide centre is potentially connected through a CDR3:peptide bond with an MHC:MHC H-bond (Table 2A & 
CDR3:pMHC Chemistry
H-bonds computed in Swiss are potential H-bonds, and to assess a given network the chemistry of each bond must be examined [28, 31] . The analyses of Tables 2A-2C indicated that a potential H-bonding network where CDR3 is connected through peptide-bonding to DRB1:peptide and DRB1:DRB1 H-bonds might correlate with the "highly-restricted" dV of V in 2IAM (297 Å 3 ) and 2IAN (270 Å 3 ). However, these networks would need to be distinct from this same type of potential network observed in 1FYT and 3T0E (Table 2B) , which have dV for V of 1747 Å 3 and 1024 Å 3 , respectively (Table 1B) . Shown is our analysis of the 2IAM-V versus 1FYT-V for contacts made by each CDR3 (Figs. 3A-D) . For 2IAM-V a potential H-bonding network involving CDR3 a.a. Y95 and H96 focused on central peptide a.a. N30 and A31 is apparent; and DRB1 a.a. Q70 and R71 appear in this same network, while the -sheet a.a. E28 (with R71:NE and R71:NH2 bonds of precisely the same distance) cancel out. More specifically, there are three potential H-bonds with the N30:O (at R71:NH1, R71:NH2, and H96:NE2); Y95 appears to H-bond to A31:O, and there is also a potential bond between Q70:OE1 and R71:NH1 Since 1FYT and 1J8H only differ via DRB1 alleles, we compared H-bonding for the two (Fig. 3B vs. 3C; 3E vs. 3F). Illustrating the importance of the Swiss computation, in Figure 3C we anticipated that the R71K polymorphism would effect three H-bonds-involving K71 in a manner similar to R71. However, as is shown in Figure 3F , R71K actually shifted peptide contacts to Q70; in-fact, K71 did not show any H-bonds. Importantly, this confirms the change in peptide conformation between the two structures as originally reported [10] , and suggests that alloreactivity of 1FYT/1J8H involves the capacity of the single G98:0 to K315:N bond maintaining the ≈ 1740 Å 3 dV of the two V (Table 1B) . Still, we had to examine the chemistry of each possible bond to arrive at feasible mechanisms; arguably, this is necessary to understand binding. 
H-Bonding Mechanisms
Shown in Figure 4A is a suitable organic reaction mechanism for the 2IAM CDR3 binding to the peptide (triosephosphate isomerse, 15mer)-HLA-DR complex (PDB ref., 12). When considering the probability of hydrogen bonds in a mechanism, we 'drew-out' all the possibilities using ChemSketch (ACD Labs; www.acdlabs.com/resources) and traced electron pathways using standard evaluations of electron configuration [31] . Thus DRB1 (B1) Q70:OE1 would be in an H-bond with B1R71:NH1 in the absence of the peptide, with the downstream effect of relieving the charge on the B1R71:NH2. Bound peptide has the same effect on R71:NH2, where the N30:O attacks the R71:NH2 (orange arrows). Here, the peptide would indirectly break the Hbond between Q70 and R71 (orange blocks). When the TCR binds, the H96:NE2 charge is preferentially attacked by the N30:O (purple arrows); this reverses the previous bond between the peptide and DRB1 (purple block) and has the downstream effect of re-forming the intra-MHC bond between Q70 and R71 (purple blocks on the orange blocks). Note, this is the only obvious mechanism that relieves both the H96 and R71 charges, and would be favoured over an A31:O attack on H96:NE2 by the neighbouring Y95 H-bond with A31:O (Fig. 4A ). Therefore, just three of the possible H-bonds are predicted; and the overall effect is a charge-relay [28, 32, 33] between the MHC, the peptide, and the TCR.
Physiologically, the charge on R71:NH2 could be initially neutralized via the neighbour Q70:OE1-subsequently replaced during processing by CLIP, and at HLA-DM exchange, with foreign peptide (ref. 5) . During T-cell conjugation with the antigen presenting cell, the TCR would replace the A30:O to R71:NH2 attack with an A30:O to H96:NE2 attack, which relays the charge back to R71:NH2-subsequently, neutralized again by Q70:OE1. While the hallmark charge-relay network of the 'catalytic triad' within serine proteases stabilizes formation of a covalent acyl-enzyme intermediate [28] ; here, a relay is utilized in a similar (albeit, noncovalent) role. Undoubtedly, this would still be a 'stabilised' transition-state [31] , i.e., given that these Hbonds are de-localised across 3/5 components of the structure [32, 33] . Figure 4 H-bonding mechanism for CDR3 binding to peptide and MHC. ChemSketch drawn mechanisms are shown for 2IAM (A) and 1FYT (B) and were based on analyses in VMD and Swiss (Fig. 3) . Not necessarily to scale. Electrons shown with arrows (purple, involving the TCR; orange related to the peptide). Possible H-bonds are shown in blue (darker shade for key TCR bond) and are crossed with a "block" line if not probable (see text).
By contrast, Figure 4B shows a suitable mechanism for the analogous CDR3 binding reaction with the influenza HA peptide-HLA-DR complex of 1FYT. The differences are the peptide and TCR, as again both 2IAM and 1FYT are DRB1*0104 structures. Similarly the peptide would replace the internal B1Q70:OE1 to B1R71:NH1 with an H-bond directly with the charged R71:NH2 via the peptide N312:O (orange arrows). Again, the TCR could replace this bond with an attack by the CDR3 (here, T97:O on N312:ND2; purple arrows). However, the downstream effect of such an attack in this case is a partial charge on N312:OD1 and an attack on R71:NH1. Note this would restore the charge on R71:NH2, effectively breaking the peptide-MHC bond. Also, despite what looks like proximity in the ChemSketch diagram, T97 is actually far removed from R71 (Fig. 3E ) such that an attack directly on R71:NH2 is not possible. Thus, because of a remaining charge on R71:NH2, the T97:O attack on N312:ND2 (with its downstream effects) would not be favoured (orange blocks). While similarly to 2IAM there is a neighbouring H-bond (in this case to Q311), the net loss of a CDR3 H-bond clearly distinguishes the two mechanisms, and shows that the 1FYT CDR3 does not favour a charge-relay mechanism; i.e., would not have the stabilized CDR3 "tether" at B1R71-ostensibly, the chemistry driving restricted dV in 2IAM. Note that the 2IAN-V mechanism appears to be similar to that of 2IAM (structures differ by a single, sufficiently "distant" a.a. of the peptide), at least as comparable with the VMD analysis (not shown). Next, 3T0E also showed the TCR:peptide:MHC:MHC type of potential network by contacts analysis (Table 2B ). Figure 5A shows the a.a. involved in this potential network using Swiss, and the proposed mechanism is shown in 5B. Note that the DRB1-4 allotype of 3T0E has the R71K polymorphism, and that the involved peptide a.a. is R9. In terms of distinguishing the mechanism from 2IAM, the question is whether the CDR3 N100 H-bond to R9 could exist with a B1:peptide H-bond. In fact, if the V closest contact N100:O is to attack the positive charge of R9:NH2 (purple arrows), it would have to compete (indirectly) with the H-bond of B1Q93:OE1 to R9:NH1 (orange arrows). Together with the B1Q99:NE2 possible bond to the same N100:O, the B1Q93 bond would be favoured; thus, the 3T0E mechanism is not similar to 2IAM, most notably because CDR3 is not likely to form an H-bond with the peptide. Note that in the related structure, PDB 3O6F [34] , this conclusion holds as well, where B1D95:OD2 has a possible H-bond to R9:NH2 at 1.6 Å (not shown); again, not favouring a CDR3 N100:O bond to the peptide. 
DQ H-Bonding Mechanisms
As shown in Table 1D , we noted the "highly-restricted" dV in V for two of the TCR:pHLA-DQ structures (4OZH & 4OZG; 267 Å 3 and 276 Å 3 , respectively) [35] . Here, the control structure is 4OZF (V dV, 554 Å 3 ), where the pMHC is the same; in-fact, these three structures only differ by their 'non-germline' TCR, i.e., by their CDR3 regions (all 38 IMGT-computed CDR3 junctions shown in Suppl.3) . Accordingly, we analysed H-bonding with Swiss-Deepview as before (Fig. 6) . While very similar, we noted the absence (Fig. 6A & B) of the DQA1, T61:OG1 role in H-bonding to V, R109:NH1 (Fig. 6C ). This is accomplished in 4OZH by preferential H-bonding to V a.a. S110 (Fig. 6A) , or sterically in 4OZG by V a.a. F110 (Fig. 6B) . Thus, only in 4OZF is T61:OG1 free to H-bond to the pivotal arginine (CDR, R109); note, this shift from R109 contacting MHC at a.a. N62 to T61 indirectly disrupts the MHC:MHC component of the charge-relay mechanism (Fig. 7C vs. 7A & B) . Crucially, the chemistry of S110 versus F110 versus A110-L111-A112-A113 in the these TCR is ultimately the result of somatic genetic construction of the CDR3 loop Again, we can think about the mechanism sequentially. First, there is internal MHC:MHC Hbonding between N11 and N62 (purple arrows, Fig. 7A & B) . This facilitates the TCR binding to peptide via a P8:O attack on the R109:NE proton (blue arrows), this leads to neutralizing the charge on R109:NH2. Uniquely here (purple arrows, Fig. 7C ), when the CDR3 is 'permissible' for the T61:OG1 to R109:NH1 H-bond, i.e., the a.a., A110-L111-A112-A113 (4OZF), this appears to preclude both N62:OD1 attack on the charged R109:NH2 and the MHC-MHC H-bond (N11:OD1 to N62:ND1); compare in Fig. 7C to 7A & B) . Thus, all three TCR (across DR and DP) which displayed highly-restricted dV, also shared the likelihood of a charge-relay mechanism of CDR3 binding, where an MHC to MHC bond is involved. Interestingly, this finding may suggest selection in celiac disease for CDR3 joints that can disrupt the N11-N62 H-bond, which is an indirect result of T61 as the source of R109 neutralization. For example, via a Th1->Th2 (Th17) functional (reduced inflammation) shift [21] ; perhaps a change in TCR affinity between receptors is superfluous, i.e., if one accepts thymic-selection based on a 'window' of TCR affinity [4, 21, 22, 30 ]. Yet, a TCR's signature dV, including the relationship between pitch and dV shown here, could be the first "phenotype" isolated to an alternative mechanism; importantly, no-less direct than affinity to H-bonding networks at the TCR:pMHC interface. 
Discussion:
We used spherical coordinates to derive a unique solved triple integral for each of the 38 Vdomains ( Figs. 1 & 2; Suppl.1 ). Using this approach the mean volumetric-density of a TCR Vdomain through the putative CDR2 scanning path was 1060 Å 3 . As indicated, ʃʃʃ v dV is a 'slice' volume of a cone with the vertex at the 'across-the-groove' MHC -helix, where maximal CDR2 scanning (d) calculates close to the actual range of -helix distances between the most N-term. and most C-term. CDR2 contacts (Tables 1A-1D ). Also, overall geometry consistent with 'across-the-groove' tethering via CDR3 (first formulated for TCR-V:pHLA-A2; ref. 17) was again, broadly apparent. Most importantly, here we found a linear relationship between V-domain pitch; calculated by:
and V-domain "dV" calculated by:
This suggests that very-low pitch may "restrict" d, i.e., the "CDR2-scanning" function. In retrospect, this confirms intuition (excluding the broader TCR-CD3 complex, of course) on possibilities for a mechanism involving just the five components. Indeed, H-bonding chemistry which effects relatively simple physics is a hallmark of quite diverse protein machinery [28, 29] . Also, TCR had k values that varied in either direction-indicating that conformation adjustments might moderate "flush" and "open" pitch without much increasing or decreasing of the dV, viz., R 2 ≈ 0.900 (Suppl.2). Thus, pitch calculated from a given V-domain's twist-tilt-sway might be a kind of "hidden" correlate of TCR-selection; although there is not available crystallography on any thymic (selecting) ligands [36] to actually test this theory. For 2IAM, there are data for the 'uncomplexed' TCR, and the CDR3 backbone is displaced ≈ 3.4 Å upon binding pMHC, while Y95 moves ≈ 9.0 Å to form the H-bond shown (Fig. 3A; PDB, ref. 12) ; indeed, the key to understanding the TCR seems to be in this relationship between two 'induced-fit' TCR conformations [4, 28, 37] . What is suggested here is a conservation/approximation of dV for the V-domains when binding the selecting (thymus) and activating (peripheral) pMHC-despite that a given pitch on the two (potentially) different ligands can change dramatically, usually it does not.
Differences between MHC alleles with regard to transplantation, so-called 'permissive' versus 'non-permissive' haplotypes, could evoke an increased number of low-concentration peptides that a non-permissive graft might present with a given (selecting) dV [38, 39] . Alternatively/historically, intrinsic TCR affinity (i.e., equilibrium and rate binding constants specified by the / TCR protein) has been used to explain thymic selection and MHC restriction [4, 40, 41] . However, as previously indicated, it is difficult to understand the intermediate ('window') nature of affinity that would result from selection in the context of a subsequent affinity-based MHC-restriction mechanism. Moreover, TCR affinity for pMHC is generally micromolar binding-weak reactions by antibody standards [42] [43] [44] . Related factors including the orientation of CDR2, 3°-structure of -chain constant domains and inter-chain disulfides, differences in CDR3 packing and the extra HV4, all likely contribute to pMHC-elicited monoclonal antibody Fab binding not like TCR [4, 45, 46] . Simply put, if positive/negative selection is based on TCR-affinity, it would be more logical that the selected repertoire reflects an optimum TCR-affinity; and thus, a qualitatively different mechanism might drive MHC restriction. In these and other regards, there is a stereochemical alternative to an affinitylimited (kinetics) binding reaction [31, 32] .
Briefly, orientation is assumed to drive the TCR-pMHC reaction involving a high(er) energy "scanning" conformer, because scanning (leading to a suitable CDR2:MHC interface) has the effect of lowering the transition-state free energy, G ǂ (Curtin-Hammett control) [31, 32, 47] . For example, in TCR like E8 (of 2IAM/2IAN) very little CDR2 scanning is apparently needed, due to the effect of the proposed charge-relay stabilised transition-state. Thus, dV is a universal consequence of the CDR3's chemistry-but usually the reaction requires more CDR2-scanning (i.e., usually V-domains have larger dV values). Simply put, binding specificity could be controlled by orientation (viz., G ǂ ) and not densities of the reactants [40, 48, 49] , or relative forward or reverse rates of the reaction, per se (ref. 31). One can envisage a free-energy 'trough' for successful induced-fit rates [37] ; the possible corollary being its establishment during thymic selection [48] . Unfortunately, technology to directly investigate the issue is also limiting [reviewed in ref . 50] . Recently, 'ensemble refinement' of crystal data with MD simulations has suggested conformational diversity in the microsecond range, but the conformational changes implicated here-in would be on the millisecond to minutes scale; in this regard, NMR of membrane-bound receptors may offer promise [50] [51] [52] [53] [54] Finally, a dynamics mechanism driven by H-bonding networks is consistent with the knowledge that different T-cell dose-response curves are found at the same TCR affinity for the same pMHC [40, [55] [56] [57] [58] . Even if we assume similar TCR-affinity for the three 4OZ structures, it appears that somatic selection directly effects H-bonds implicated in V-domain dynamics (dV), and (indirectly) germline:germline contacts between CDR2 and the MHC -helices (d) [24, 44, 49, [59] [60] [61] . Stabilization of H-bonding via charge-relays is implicated for V-domains with verylow pitch angles, as specified by the twist-tilt-sway (viz., orientation) and highly-restricted dV. What can change is the measured pitch angle. Thus, an orientation selected on a thymic pMHC-II could specify particular dV (characterized by the calculated pitch); and speculatively, this dV must be approximated on a peripheral pMHC-II, i.e., leading to 'recognition' of this pMHC-II during an immune response. The 'plasticity' of pitch during recognition could further 'induced fit' and ostensibly allows some recapitulations on a pMHC-II with the different (peripheral) peptide; in effect, MHC restriction [4, 7, 15, 30] . Again, usually we see k values close to unity. While there are myriad 'downstream' implications, taken together, these data support that Vdomain rotation and germline to germline contacts between TCR and pMHC both depend upon somatic TCR H-bonding with a highly-conserved, across-the-groove MHC motif [17, 19, 24, 30, 44] . In this case, the DRB1/DQB1 sequence, Y60-W-N-S-Q-K-D-L/I-L-E-Q/R70, which spans closest contacts across CDR3 of the DR and DQ TCR:pMHC-II structures (Tables 1A-1D ), conserved throughout human and primate alleles (not shown; NCBI BLAST data, 09/03/2019).
Methods:

PDB Analysis
VMD-1.9.1 software (www.ks.uiuc.edu) was used for PDB files downloaded via NCBI (www.ncbi.nlm.nih.gov) from the RSCB-PDB (www.rscb.org); views normalized with the VMD xyz-axis tool; alpha carbon (C) main-chains in new cartoon; all alleles named per NCBI annotation. Euler's methods (www.mathword.wolfram.com/EulerAngles.html) were the basis for the specific angle analyses, as previously reported. Briefly, three angles corresponding to the twist (), tilt (), and sway () of each domain over the pMHC were measured from fixed C through the 19 structures: (i) in-plane to the MHC-groove {twist = }, with (ii) displacements perpendicular to the groove {tilt = }, including (iii) side-to-side variation {sway = }. The a.a. positions used as coordinates for angular measures across structures were fixed; see previous. The "incline" of a V-domain, {pitch =  m }, was approximated (calculated) by the equation:  c = [ ÷ ( + )]  (see also Results, Tables 1A-1D ). Pitch was also measured by using the closest determined CDR2 contact C for an angle across-the-groove to the V-domain's closest CDR3 contact with an -helix side-chain (vertex), then back to said CDR2 closest contact within the opposite -helix (≈ 2-fold symmetry); angular value in degrees via the VMD angle-label tool. Linear regression analysis by MS-Excel (Suppl.2); and statistics by paired two-tailed Student's ttest (www.insilico-net/tools/statistics/ttest).
Contacts Analysis
All measures were performed with Swiss or VMD-1.9.1 as is specified in Results. Closest contacts in angstroms (Å) were determined by examining appropriate coordinates between structures (computed in Swiss, or measured/computed in VMD). Individual atomic contacts are named per software annotation. DRA chain contacts are abbrv. "A1" to avoid confusion with single-letter a.a. code for alanine (A); potential H-bond networks are colour-coded as is described in Table footnotes and the text.
CDR3 Joint Analysis
Nucleotide sequences for all CDR3 of TCR were specified from PDB files (Suppl.3). TCR a.a. sequences were reverse translated using the SMS tool at www.bioinformatics.org. These were then imported into IMGT algorithms for joint analysis (www.imgt.org). Amino acid sequences of resulting CDR3 joints were determined by the IMGT algorithm; consensus IMGT numbering. The pMHC contacts were computed by bond-length measurement from the PDB files with VMD, as previously described.
H-Bonding Mechanisms
Hydrogen (H) bonds were estimated either with VMD, or (more accurately) with Swiss. In Swiss, H-bonds are calculated after computing hydrogens to the structures. H-bond distances were used as a factor in determining suitable organic reaction mechanisms, where relevant side-chains were reproduced with Chemsketch (www.acdlabs.com/resources). Standard evaluations of electron configuration per relevant atoms were used to predict electron flows [31] .
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